check_circleStudy Completed

Tinea corporis, Tinea inguinalis

Bayer Identifier:

Trial_0113

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

EU CT Number:

Not Available
BAY H 4502-1% cream in comparison with placebo cream in cases of Tinea corporis / Tinea inguinalis

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

N/A
  • -

  • -

Trial summary

Enrollment Goal
39
Trial Dates
November 1979 - June 1980
Phase
Phase 2
Could I Receive a placebo
N/A
Products
Mycospor/Canesten Extra (Bifonazole, BAYH4502)
Accepts Healthy Volunteer
N/A

Trial design

BAY H 4502-1% cream: Effectiveness and tolerance in comparison with placebo cream in cases of Tinea corporis / Tinea inguinalis (Phase II b)
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.